Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BACE1 | P56817 | 9/20 | 0.67 |
| ▸ | SLC6A11 | P48066 | 1/20 | 0.67 |
| ▸ | BCHE | P06276 | 9/20 | 0.59 |
| ▸ | ANPEP | P15144 | 1/20 | 0.53 |
| ▸ | ATM | Q13315 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8955274 | 0.92 | BACE1 (0.57) | BACE1SLC6A11BCHEANPEPATM | |
| SCHEMBL8732014 | 0.90 | BACE1 (0.55) | BACE1SLC6A11BCHEANPEPATM | |
| SCHEMBL8731471 | 0.90 | BACE1 (0.55) | BACE1SLC6A11BCHEANPEPATM | |
| SCHEMBL8731402 | 0.89 | BACE1 (0.56) | BACE1SLC6A11BCHE | |
| SCHEMBL8734184 | 0.89 | BCHE (0.58) | BACE1SLC6A11BCHEATM | |
| SCHEMBL8734450 | 0.87 | BCHE (0.68) | BACE1SLC6A11BCHEANPEPATM | |
| SCHEMBL7610027 | 0.87 | BACE1 (0.71) | BACE1SLC6A11BCHE | |
| SCHEMBL7610032 | 0.87 | BACE1 (0.71) | BACE1SLC6A11BCHE | |
| SCHEMBL8734455 | 0.86 | L3MBTL1 (0.52) | BACE1SLC6A11BCHEANPEPATM | |
| SCHEMBL7647681 | 0.86 | L3MBTL1 (0.52) | BACE1SLC6A11BCHEANPEPATM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5708004-A | ENZYME INHIBITORS FOR TREATMENT OF AIDS | MONSANTO COMPANY (US) | 1998-01-13 | — | — | US | disclosed |
| US-5703076-A | TREATING HIV, AIDS | G. D. SEARLE & CO. (US) | 1997-12-30 | — | — | US | disclosed |
| US-5698569-A | Retroviral protease inhibitors | G. D. SEARLE & CO. (US) | 1997-12-16 | — | — | US | disclosed |
| US-5510349-A | HUMAN IMMUNODEFICIENCY VIRUS | G.D. SEARLE & CO. (US) | 1996-04-23 | — | — | US | disclosed |
| US-5510487-A | TREATING HUMAN IMMUNODEFICIENCY VIRUS INFECTIONS | G.D. SEARLE & CO. (US) | 1996-04-23 | — | — | US | disclosed |
| US-5510378-A | Retroviral protease inhibitors | G.D. SEARLE & CO. (US) | 1996-04-23 | — | — | US | disclosed |